when you start a new mouse model project by the end of 2019. Contact us now for details!
goGermline is a revolutionary new technology to generate knockout and knock-in mouse models. Our fastest project has been completed in 20 weeks.
Ideal for compromised ES cells that normally would not give germline transmission, including repository ES cell clones.
Greatly improves animal welfare by addressing the 3Rs: replace, reduce, refine. We can guarantee that only ES cell derived animals are produced at chimera breeding.
Ozgene is an Australian company that generates customised genetically modified mice for drug validation and medical research trials worldwide. Using Lean Management, we are able to efficiently and consistently provide our clients with high quality mouse models so that you too, can advance humanity and inspire curiosity.
Did you know that Ozgene’s founders, Dr Frank Koentgen and Dr Gabi Suess, were the first to successfully produce a C57BL/6 knockout mouse in 1993? Ozgene was founded in 1999 based on that initial accomplishment. Since then, we have established a long history of continued success. Today Ozgene is one of the leading companies providing genetically customised mice for researchers around the world.
Ozgene mice can be found all over the globe. This is evidenced by the distribution of published papers that reference mice created by Ozgene. We currently have over 400 papers published, more than any other competing company. We would love to add your paper to the list, so if you have a project in mind, please see our current services below and contact us for a confidential, obligation free assessment.
To celebrate Ozgene's 20th birthday, get 20 weeks of line maintenance free of charge when you start a new mouse model project by the end of 2019. Contact us for details.
Read the newsletter for latest insights into cancer research, Ozgene LLC launch in Indianapolis, recent publications, the ISTT2019 poster and the latest timelines.
Did you see the latest data on goGermline by Ozgene® expediting time to first experimental cohorts at the ISTT2019 meeting in Kobe?